Related Experiment Videos
Financial managers' costing expertise is needed in clinical trials
D A West1, E A Balas, T D West
1College of Business and Public Administration, Department of Health Management and Informatics, School of Medicine, University of Missouri-Columbia, USA.
Journal of Health Care Finance
|August 29, 2000
Summary
Standardizing cost calculations in clinical trials is crucial for financial transparency and efficiency. This study proposes a new format to improve economic analyses in healthcare research.
Area of Science:
- Health economics
- Clinical trial management
- Healthcare financial analysis
Background:
- Clinical trials provide evidence on outcomes but often lack comprehensive financial data.
- Incomplete economic analyses in trials hinder cost control and efficiency identification.
- Standardized cost calculations are needed for better healthcare technology assessment.
Purpose of the Study:
- To propose a standard costing format for clinical trial reports.
- To enhance the financial information within published clinical trials.
- To facilitate cost-effectiveness analysis in healthcare interventions.
Main Methods:
- Analysis of 97 published clinical trial reports.
- Identification of common elements and gaps in economic data.
- Development of a proposed standard costing format.
Main Results:
- Few published trials include economic analyses, and available data are often incomplete.
- A need for standardized financial reporting in clinical trials was identified.
- A proposed standard costing format was developed based on the analysis.
Conclusions:
- Implementing a standard costing format can improve the accuracy and replicability of financial information in clinical trials.
- Healthcare financial managers possess the expertise to implement and interpret standardized cost calculations.
- Active involvement of financial managers is key to achieving a standard costing format for clinical trials.